Ebola virus - biological weapons?
Why did the US Department of Defense, and not the pharmaceutical companies, finance the development of the Ebola vaccine?
For the first time, the Ebola virus was discovered in the 1976 year in the region of the same name river in Africa. Fever has several strains, and in some of them the mortality rate reaches 90%. However, the disease never takes on the character of a pandemic - mainly due to the fact that the infected die very quickly. And if they manage to transmit the virus to someone within their village or city, then it rarely breaks out of the country.
So far there is no vaccine against this fever, no effective treatment. Pharmacological companies refused to engage in the development of drugs against the Ebola virus, since such a project seemed to them economically unprofitable: the sales market was too small. This means that repelling attachments just will not work. However, the US Department of Defense held a different position and actively financed the creation of a vaccine. However, when she successfully passed clinical trials on animals, the project for some reason was closed. And here a completely natural question appears: why are the US military interested in the Ebola virus and why are they stopping the development of a vaccine against it (despite the fact that the drug was almost ready)?
Very strange patent
The US Centers for Disease Control and Prevention (CDC) owns one curious patent that extends to the Ebola virus strain known as EboBun. The patent was obtained in 2010 year, and its number is CA2741523A1. The patent applicant is none other than the government of the United States of America (represented by a representative from the CDC). The patent description states that it contains an isolated strain of the human Ebola virus that was found in the blood of affected people from Uganda.
It is worth noting that the Ebola fever that raged in West Africa in February of this year has a different strain. However, the first infected with this virus for some reason were delivered to the United States. Some experts believe that this was done with special intent: it is likely that the CDC is seeking to expand its patent portfolio. There are also more radical opinions that state that Ebola is an artificial disease, that is, biological weaponscreated by human hands.
Subtleties of patenting
A patent is the exclusive right of a person or organization to a specific invention. This right does not allow other people and companies to use this invention for personal gain. The CDC patent obtained for the Ebola virus strain effectively proclaims the United States as the developer and sole owner of this disease. And this means that all work related to this patent, for example, the development of a vaccine, is entitled to be carried out only by the American authorities. It turns out that if suddenly there is an outbreak of Ebola fever somewhere with the EboBun strain, then virtually no one can create a cure for it. In addition to the United States, of course.
But that's not all. The US government also claims that, since all Ebola strains are similar in about 70% or more, the patent will extend to them. In other words, according to the laws of the United States of America, they are the developers and sole owners of the Ebola virus.
What is the US patent for the Ebola virus?
Patenting a deadly disease in itself looks very strange - otherwise why no one has yet claimed its right to cancer or diabetes? No less strange is the delivery of patients with the Ebola virus to the USA: there are no medical reasons for this. In any case, so say the eminent American doctors. There is no economic benefit for such a project, as the market is too narrow. Why then does the USA need this patent?
There are two theories (put forward, by the way, by American experts). One of them sends to a mass panic about bird flu, and then swine flu. There is an accidental leak of the virus from the laboratories (or, alternatively, the escape of infected people), followed by an outbreak of the disease in the city, country and world. And it doesn't even matter that there can be virtually no epidemic. After all, the same Ebola virus symptoms are hardly different from the common cold - fever, aching joints, headache and weakness. Against the background of mass hysteria, an unknown pharmacological company, which already has a ready-made vaccine, appears before. The drug is bought by millions of people and governments. And someone from the seemingly economically unprofitable project - the development of a drug for a local virus - receives an unprecedented profit.
The second scenario is even worse, as it tells about the development of biological weapons. Given the nature of the spread of Ebola and the high lethality of the virus, it can be concluded that it is possible to kill people with a point - villages, cities ... or countries. And if the aggressor has an already developed and tested vaccine in reserve for unforeseen circumstances, the biological war may well turn out to be quick and successful. For the USA.
- Arina Akhmatova
- http://www.km.ru/science-tech/2014/08/08/otkrytiya-v-oblasti-meditsiny-i-zdorovya/747078-virus-ebola-biologicheskoe-o
Information